The reality star and bride-to-be Tweets about her battle with the skin condition
"People don't understand the pressure on me to look perfect," the reality star says
Drugs that treat psoriasis and rheumatoid arthritis, or RA, by suppressing the immune system may also reduce the risk of developing diabetes, at least in people who already have one of these conditions, according to a new study in the Journal of the American Medical Association.
The government is warning that taking the psoriasis drug Raptiva could result in serious brain infection and even death.
Others "didn't want to hang out with me or touch me," the singer says of her psoriasis
The singer shares her experience in a new PSA to raise awareness of the disease
Schering-Plough may have lost billions of dollars in the fourth quarter from an acquisition, but its stock jumped Tuesday as the drugmaker's earnings without charges beat expectations.
Biotech Amgen on Thursday reported an increase in earnings and a decrease in sales for the fourth quarter, beating Wall Street's forecast.
Abbott Laboratories, a maker of drugs and medical devices, reported on Wednesday a jump in sales and earnings that beat Wall Street's estimates.
The FDA approved Abbott's blockbuster drug Humira for yet another indication, psoriasis, the drugmaker said Friday.
Psoriasis is an inflammatory skin condition that affects up to 5 million Americans. CNN learned more about psoriasis from Dr. Mathew Avram, director of the Massachusetts General Hospital Dermatology Laser and Cosmetics Center.
The biotech Amgen reported first-quarter earnings Monday that matched expectations, though its revenue fell just short of forecasts.
Senior Democrats and Republicans in Congress are hard at work on bills that would provide millions of Americans with cheaper copies of biotech drugs that can cost hundreds of thousands of dollars a year, a news report said Saturday.
Abbott Laboratories is trying to get its top-selling blockbuster drug approved for yet another use, which could lead to further sales.
A surge in Amgen Inc's fourth-quarter earnings fell short of analyst projections, but the company's sales topped expectations.
Abbott Labs' fast-growing flagship drug Humira is grabbing market share and making money ... and now the company is trying to win the blessings of the FDA to make more.
Amgen Inc., the world's biggest biotech developer, beat earnings expectations for the first quarter Tuesday, but analysts were still skeptical about the company's performance.
Drug safety made headlines in the major medical journals this week when noted Cleveland Clinic cardiologists came up with a disturbing analysis about a new diabetes drug that is just a hair away from approval by the Food and Drug Administration.
The black box label is the most potent warning in the Food and Drug Administration's arsenal, but it is not necessarily a death knell for drug sales, analysts say.
Johnson & Johnson says its rheumatoid arthritis drug Remicade may put patients at higher risk for lymphoma, and the company is sending out warning letters to physicians.
Fortune: Elite Factoriesupdated: Mon Sep 06 2004 00:01:00
A common thread connects this year's standouts: They all responded to crisis by radically changing the way they make things. Autoliv reprocessed its factory to fend off stiff competition in airbags...
The Empire State ballroom at the Grand Hyatt Hotel in midtown Manhattan typically serves as the setting for the kind of stuffy, state-of-a-business luncheons that are more snooze inducing than buzz...
The economy seems to be chugging back onto the right track, and Wall Street wisdom (no jokes, please) has stocks rising this year after two consecutive annual declines. But before you jump for joy,...
For years Amgen has seemed biotechnology's best answer to the likes of Merck--a sector leader with so much heft and momentum that you'd recommend its stock to your mom. But now making that analogy ...
The first wave in biotechnology investing arrived back in the late 1980s, when revolutionary new medicines created by pioneers like Amgen alerted investors to the fledgling sector's potential. The ...
On Dec. 17, Amgen, the flagship company of the biotechnology world, closed the biggest merger in the sector's history. It agreed to pay $16 billion to buy rival Immunex, primarily for the right to ...
Patients who want the rheumatoid arthritis-fighting drug Enbrel have to show a special card to their pharmacist, who then verifies that the patient is enrolled in the Enbrel program before dispensi...
Like any good family practitioner, Dr. Reginald Parker believes in protecting against loss. So he begins his financial exams with some basic questions: What stocks do the mutual funds own? What ind...
Fortune: THE TICKERupdated: Mon Oct 27 1997 00:01:00
FREEING A MICROSOFT SLAVE
In a dimly lit operating room at the Thompson Cancer Survival Center in Knoxville, Tennessee, a surgeon uses an endoscope to guide an optical fiber down the throat of a patient afflicted with cance...
© 2013 Cable News Network. Turner Broadcasting System, Inc. All Rights Reserved.
|